Evidence of inflammatory cell involvement in brain arteriovenous malformations

Neurosurgery

Volumn 62, Issue 6, 2008, Pages 1340-1349

  Chen, Yongmei ^a,b   Zhu, Wei ^a,b   Bollen, Andrew W ^a,b   Lawton, Michael T ^b   Barbara, Nicholas M ^b   Dowd, Christopher F ^b   Hashimoto, Tomoki ^a,b   Yang, Guo Yuan ^b   Young, William L ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CD68; Inflammation; Myeloperoxidase; Vascular malformations

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD31 ANTIGEN; CD68 ANTIGEN; CELL MARKER; GELATINASE B; MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BLOOD VESSEL WALL; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN CORTEX; BRAIN TISSUE; CELL COUNT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; INNER CELL MASS; LOBECTOMY; MACROPHAGE; MALE; MICROGLIA; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TEMPORAL LOBE; TISSUE SECTION;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CASE-CONTROL STUDIES; DISEASE MODELS, ANIMAL; HUMANS; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; LEUKOCYTES; MACROPHAGES; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; PEROXIDASE;

EID: 56849083825     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.neu.0000333306.64683.b5     Document Type: Article

References (47)

1. Achrol AS, Pawlikowska L, McCulloch CE, Poon KY, Ha C, Zaroff JG, Johnston SC, Lee C, Lawton MT, Sidney S, Marchuk DA, Kwok PY, Young WL; UCSF BAVM Study Project: Tumor necrosis factor-alpha-238G>A promoter polymorphism is associated with increased risk of new hemorrhage in the natural course of patients with brain arteriovenous malformations. Stroke 37:638-639, 2006.
2. Allavena P, Sica A, Solinas G, Porta C, Mantovani A: The inflammatory microenvironment in tumor progression: The role of tumor-associated macrophages. Crit Rev Oncol Hematol 66:1-9, 2007.
3. Audrain MA, Baranger TA, Moguilevski N, Martin SJ, Devys A, Lockwood CM, Muller JY, Esnault VL: Anti-native and recombinant myeloperoxidase monoclonals and human autoantibodies. Clin Exp Immunol 107:127-134, 1997.
4. Campana D, Thompson JS, Amlot P, Brown S, Janossy G: The cytoplasmic expression of CD3 antigens in normal and malignant cells of the T lymphoid lineage. J Immunol 138:648-655, 1987.
5. Cavanagh SP, Gough MJ, Homer-Vanniasinkam S: The role of the neutrophil in ischaemia-reperfusion injury: Potential therapeutic interventions. Cardiovasc Surg 6:112-118, 1998.
6. Chen Y, Fan Y, Poon KY, Achrol AS, Lawton MT, Zhu Y, McCuiloch CE, Hashimoto T, Lee C, Barbaro NM, Bollen AW, Yang GY, Young WL: MMP-9 expression is associated with leukocytic but not endothelial markers in brain arteriovenous malformations. Front Biosci 11:3121-3128, 2006.
7. Chen Y, Pawlikowska L, Yao JS, Shen F, Zhai W, Achrol AS, Lawton MT, Kwok PY, Yang GY, Young WL: Interleukin-6 involvement in brain arteriovenous malformations. Ann Neurol 59:72-80, 2006.
8. Choi JH, Mohr JP: Brain arteriovenous malformations in adults. Lancet Neurol 4:299-308, 2005.
9. Chou WH, Choi DS, Zhang H, Mu D, McMahon T, Kharazia VN, Lowell CA, Ferriero DM, Messing RO: Neutrophil protein kinase Cdelta as a mediator of stroke-reperfusion injury. J Clin Invest 114:49-56, 2004.
10. Chyatte D, Bruno G, Desai S, Todor DR: Inflammation and intracranial aneurysms. Neurosurgery 45:1137-1147, 1999.
11. Dahlqvist K, Umemoto EY, Brokaw JJ, Dupuis M, McDonald DM: Tissue macrophages associated with angiogenesis in chronic airway inflammation in rats. Am J Respir Cell Mol Biol 20:237-247, 1999.
12. Dasu MR, Barrow RE, Spies M, Herndon DN: Matrix metalloproteinase expression in cytokine stimulated human dermal fibroblasts. Burns 20:527-531, 2003.
13. Daugherty A, Dunn JL, Rateri DL, Heinecke JW: Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest 94:437-444, 1994.
14. del Zoppo GJ, Schmid-Schönbein GW, Mori E, Copeland BR, Chang CM: Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke 22:1276-1283, 1991.
15. Ferroni P, Basili S, Martini F, Cardarello CM, Ceci F, Di Franco M, Bertazzoni G, Gazzaniga PP, Alessandri C: Serum metalloproteinase 9 levels in patients with coronary artery disease: A novel marker of inflammation. J Investig Med 51:295-300, 2003.
16. Fleetwood IG, Steinberg GK: Arteriovenous malformations. Lancet 359:863-873, 2002.
17. Frösen J, Piippo A, Paetau A, Kangasniemi M, Niemelä M, Hernesniemi J, Jääskeläinen J: Remodeling of saccular cerebral artery aneurysm wall is associated with rupture: Histological analysis of 24 unruptured and 42 ruptured cases. Stroke 35:2287-2293, 2004.
18. Halim AX, Singh V, Johnston SC, Higashida RT, Dowd CF, Halbach VV, Lawton MT, Gress DR, McCulloch CE, Young WL; UCSF BAVM Study Project. Brain Arteriovenous Malformation: Characteristics of brain arteriovenous malformations with coexisting aneurysms: A comparison of two referral centers. Stroke 33:675-679, 2002.
19. Hao Q, Chen Y, Zhu Y, Fan Y, Palmer D, Su H, Young WL, Yang GY: Neutrophil depletion decreases VEGF-induced focal angiogenesis in the mature mouse brain. J Cereb Blood Flow Metab 27:1853-1860, 2007.
20. Hashimoto T, Lawton MT, Wen G, Yang GY, Chaly T Jr, Stewart CL, Dressman HK, Barbaro NM, Marchuk DA, Young WL: Gene microarray analysis of human brain arteriovenous malformations. Neurosurgery 54:410-425, 2004.
21. Hashimoto T, Meng H, Young WL: Intracranial aneurysms: Links between inflammation, hemodynamics and vascular remodeling. Neurol Res 28:372-380, 2006.
22. Hashimoto T, Wen G, Lawton MT, Boudreau NJ, Bollen AW, Yang GY, Barbaro NM, Higashida RT, Dowd CF, Halbach VV, Young WL; University of California, San Francisco BAVM Study Group: Abnormal expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in brain arteriovenous malformations. Stroke 34:925-931, 2003.
23. Hashimoto T, Wu Y, Lawton MT, Yang GY, Barbaro NM, Young WL: Coexpression of angiogenic factors in brain arteriovenous malformations. Neurosurgery 56:1058-1065, 2005.
24. Hashimoto T, Yang GY, Young WL: Abnormal expression of MMP9 and TIMPs in brain arteriovenous malformations. Anesthesiology 96:A-721, 2002.
25. Hultin LE, Hausner MA, Hultin PM, Giorgi JV: CD20 (pan-B cell) antigen is expressed at a low level on a subpopulation of human T lymphocytes. Cytometry 14:196-204, 1993.
26. Kazi M, Thyberg J, Religa P, Roy J, Eriksson P, Hedin U, Swedenborg J: Influence of intraluminal thrombus on structural and cellular composition of abdominal aortic aneurysm wall. J Vasc Surg 38:1283-1292, 2003.
27. Klebanoff SJ: Myeloperoxidase. Proc Assoc Am Physicians 111:383-389, 1099.
28. Klebanoff SJ: Myeloperoxidase: Friend and foe. J Leukoc Biol 77:598-625, 2005.
29. Lifson JD, Rossio JL, Piatak M Jr, Parks T, Li L, Kiser R, Coalter V, Fisher B, Flynn BM, Czajak S, Hirsch VM, Reimann KA, Schmitz JE, Ghrayeb J, Bischofberger N, Nowak MA, Desrosiers RC, Wodarz D: Role ot CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment. J Virol 75: 10187-10199, 2001.
30. Lucchesi BR, Mullane KM: Leukocytes and ischemia-induced myocardial injury. Annu Rev Pharmacol Toxicol 26:201-224, 1986.
31. Maier CM, Hsieh L, Yu F, Bracci P, Chan PH: Matrix metalloproteinase-9 and myeloperoxidase expression: Quantitative analysis by antigen immunohistochemistry in a model of transient focal cerebral ischemia. Stroke 36:1169-1174, 2004.
32. Moulton KS, Vakili K, Zurakowski D, Soliman M, Butterfield C, Sylvin E, Lo KM, Gillies S, Javaherian K, Folkman J: Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci U S A 100:4736-4741, 2003.
33. Murakami M, Iwai S, Hiratsuka S, Yamauchi M, Nakamura K, Iwakura Y, Shibuya M: Signaling of vascular endothelial growth factor receptor-1 tyrosine kinase promotes rheumatoid arthritis through activation of monocytes/ macrophages. Blood 108:1849-1836, 2006.
34. Nicholls SJ, Hazen SL: Myeloperoxidase and cardiovascular disease. Arterioscler Thromb Vasc Biol 25:1102-1111, 2005.
35. Opdenakker G, Van den Steen PE, Dubois B, Nelissen I, Van Coillie E, Masure S, Proost P, Van Damme J: Gelatinase B functions as regulator and effector in leukocyte biology. J Leukoc Biol 69:851-859, 2001.
36. Parums DV, Cordell JL, Micklem K, Heryet AR, Gatter KC, Mason DY: IC70: A new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J Clin Pathol 43:752-757, 1990.
37. Pawlikowska L, Tran MN, Achrol AS, McCulloch CE, Ha C, Lind DL, Hashimoto T, Zaroff J, Lawton MT, Marchuk DA, Kwok PY, Young WL; UCSF BAVM Study Project: Polymorphisms in genes involved in inflammatory and angiogenic pathways and the risk of hemorrhagic presentation of brain arteriovenous malformations. Stroke 35:2294-2300, 2004.
38. Pober JS, Sessa WC: Evolving functions of endothelial cells in inflammation. Nat Rev Immunol 7:803-815, 2007.
39. Pugin J, Widmer MC, Kossodo S, Liang CM, Preas HL 2nd, Suffredini AF: Human neutrophils secrete gelatinase B in vitro and in vivo in response to endotoxin and proinflammatory mediators. Am J Respir Cell Mol Biol 20:458-464, 1999.
40. Shenkar R, Elliott JP, Diener K, Gault J, Hu LJ, Cohrs RJ, Phang T, Hunter L, Breeze RE, Awad IA: Differential gene expression in human cerebrovascular malformations. Neurosurgery 52:463-478, 2003.
41. Shimakura A, Kamanaka Y, Ikeda Y, Kondo K, Suzuki Y, Umemura K: Neutrophil elastase inhibition reduces cerebral ischemic damage in the middle cerebral artery occlusion. Brain Res 858:55-60, 2000.
42. Soares HD, Hicks RR, Smith D, McIntosh TK: Inflammatory leukocytic recruitment and diffuse neuronal degeneration are separate pathological processes resulting from traumatic brain injury. J Neurosci 15:8223-8233, 1995.
43. Sugiyama S, Okada Y, Sukhova GK, Virmani R, Heinecke IW, Libby P: Macrophage myeloperoxidase regulation bv granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol 158:879-891, 2001.
44. Tejima E, Zhao BQ, Tsuji K, Rosell A, van Leven K, Gonzalez RG, Montaner J, Wang X, Lo EH: Astrocytic induction of matrix metalloproteinase-9 and edema in brain hemorrhage. J Cereb Blood Flow Metab 27:460-468, 2007.
45. Wize J, Sopata I, Smerdel A, Maslinski S: Ligation of selectin L and integrin CD11b/CD18 (Mac-1) induces release of gelatinase B (MMP-9) from human neutrophils. Inflamm Res 47:325-327, 1998.
46. Yan L, Borregaard N, Kjeldsen L, Moses MA: The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-assoeiated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem 276:37258-37265, 2001.
47. Young WL, Yang GY: Are there genetic influences on sporadic brain arteriovenous malformations? Stroke 35 [Suppl 1]:2740-2745, 2004.